GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently gaining a major focus in healthcare investigation, largely due to its impressive impact on treating diseases such as second type diabetes and obesity. Recent studies have revealed that in addition to glucose management, GLP-